Hollsteen
← Meta

Cash and equivalents

Balance – as of period end · $B

QuartersFiscal years

$BCash and equivalents · Q1 2016: $6.5B · 10-Q 0001326801-16-000067 filed Apr 28, 2016Cash and equivalents · Q2 2016: $5.1B · 10-Q 0001326801-16-000082 filed Jul 28, 2016Cash and equivalents · Q3 2016: $6.0B · 10-Q 0001326801-16-000087 filed Nov 3, 2016Cash and equivalents · Q4 2016: $8.9B · 10-K 0001326801-17-000007 filed Feb 3, 2017Cash and equivalents · Q1 2017: $7.1B · 10-Q 0001326801-17-000024 filed May 4, 2017Cash and equivalents · Q2 2017: $6.3B · 10-Q 0001326801-17-000038 filed Jul 27, 2017Cash and equivalents · Q3 2017: $7.2B · 10-Q 0001326801-17-000053 filed Nov 2, 2017Cash and equivalents · Q4 2017: $8.1B · 10-K 0001326801-18-000009 filed Feb 1, 2018Cash and equivalents · Q1 2018: $12.1B · 10-Q 0001326801-18-000032 filed Apr 26, 2018Cash and equivalents · Q2 2018: $11.6B · 10-Q 0001326801-18-000057 filed Jul 26, 2018Cash and equivalents · Q3 2018: $9.6B · 10-Q 0001326801-18-000067 filed Oct 31, 2018Cash and equivalents · Q4 2018: $10.0B · 10-K 0001326801-19-000009 filed Jan 31, 2019Cash and equivalents · Q1 2019: $11.1B · 10-Q 0001326801-19-000037 filed Apr 25, 2019Cash and equivalents · Q2 2019: $13.9B · 10-Q 0001326801-19-000055 filed Jul 25, 2019Cash and equivalents · Q3 2019: $16.0B · 10-Q 0001326801-19-000069 filed Oct 31, 2019Cash and equivalents · Q4 2019: $19.1B · 10-K 0001326801-20-000013 filed Jan 30, 2020Cash and equivalents · Q1 2020: $23.6B · 10-Q 0001326801-20-000048 filed Apr 30, 2020Cash and equivalents · Q2 2020: $21.0B · 10-Q 0001326801-20-000076 filed Jul 31, 2020Cash and equivalents · Q3 2020: $11.6B · 10-Q 0001326801-20-000084 filed Oct 30, 2020Cash and equivalents · Q4 2020: $17.6B · 10-K 0001326801-21-000014 filed Jan 28, 2021Cash and equivalents · Q1 2021: $19.5B · 10-Q 0001326801-21-000033 filed Apr 29, 2021Cash and equivalents · Q2 2021: $16.2B · 10-Q 0001326801-21-000049 filed Jul 29, 2021Cash and equivalents · Q3 2021: $14.5B · 10-Q 0001326801-21-000065 filed Oct 26, 2021Cash and equivalents · Q4 2021: $16.6B · 10-K 0001326801-22-000018 filed Feb 3, 2022Cash and equivalents · Q1 2022: $14.9B · 10-Q 0001326801-22-000057 filed Apr 28, 2022Cash and equivalents · Q2 2022: $12.7B · 10-Q 0001326801-22-000082 filed Jul 28, 2022Cash and equivalents · Q3 2022: $14.3B · 10-Q 0001326801-22-000108 filed Oct 27, 2022Cash and equivalents · Q4 2022: $14.7B · 10-K 0001326801-23-000013 filed Feb 2, 2023Cash and equivalents · Q1 2023: $11.6B · 10-Q 0001326801-23-000067 filed Apr 27, 2023Cash and equivalents · Q2 2023: $28.8B · 10-Q 0001326801-23-000093 filed Jul 27, 2023Cash and equivalents · Q3 2023: $36.9B · 10-Q 0001326801-23-000103 filed Oct 26, 2023Cash and equivalents · Q4 2023: $41.9B · 10-K 0001326801-24-000012 filed Feb 2, 2024Cash and equivalents · Q1 2024: $32.3B · 10-Q 0001326801-24-000049 filed Apr 25, 2024Cash and equivalents · Q2 2024: $32.0B · 10-Q 0001326801-24-000069 filed Aug 1, 2024Cash and equivalents · Q3 2024: $43.9B · 10-Q 0001326801-24-000081 filed Oct 31, 2024Cash and equivalents · Q4 2024: $43.9B · 10-K 0001326801-25-000017 filed Jan 30, 2025Cash and equivalents · Q1 2025: $28.8B · 10-Q 0001326801-25-000054 filed May 1, 2025Cash and equivalents · Q2 2025: $12.0B · 10-Q 0001628280-25-036791 filed Jul 31, 2025Cash and equivalents · Q3 2025: $10.2B · 10-Q 0001628280-25-047240 filed Oct 30, 2025Cash and equivalents · Q4 2025: $35.9B · 10-K 0001628280-26-003942 filed Jan 29, 2026Cash and equivalents · Q1 2026: $23.4B · 10-Q 0001628280-26-028526 filed Apr 30, 2026Cash and equivalents · Q2 2026: $15.5B · 10-Q 0001628280-26-050705 filed Jul 30, 202612.715.56.543.9Q1 2016Q2 2026Q2 2022
$BCash and equivalents · Q2 2021: $16.2B · 10-Q 0001326801-21-000049 filed Jul 29, 2021Cash and equivalents · Q3 2021: $14.5B · 10-Q 0001326801-21-000065 filed Oct 26, 2021Cash and equivalents · Q4 2021: $16.6B · 10-K 0001326801-22-000018 filed Feb 3, 2022Cash and equivalents · Q1 2022: $14.9B · 10-Q 0001326801-22-000057 filed Apr 28, 2022Cash and equivalents · Q2 2022: $12.7B · 10-Q 0001326801-22-000082 filed Jul 28, 2022Cash and equivalents · Q3 2022: $14.3B · 10-Q 0001326801-22-000108 filed Oct 27, 2022Cash and equivalents · Q4 2022: $14.7B · 10-K 0001326801-23-000013 filed Feb 2, 2023Cash and equivalents · Q1 2023: $11.6B · 10-Q 0001326801-23-000067 filed Apr 27, 202312.711.616.216.6Q2 2021Q1 2023Q2 2022
Q2 2022
12.7$B
All values (42)
PeriodValue ($B)Status
Q2 202615.5reported
Q1 202623.4reported
Q4 202535.9reported
Q3 202510.2reported
Q2 202512.0reported
Q1 202528.8reported
Q4 202443.9reported
Q3 202443.9reported
Q2 202432.0reported
Q1 202432.3reported
Q4 202341.9reported
Q3 202336.9reported
Q2 202328.8reported
Q1 202311.6reported
Q4 202214.7reported
Q3 202214.3reported
Q2 202212.7reported
Q1 202214.9reported
Q4 202116.6reported
Q3 202114.5reported
Q2 202116.2reported
Q1 202119.5reported
Q4 202017.6reported
Q3 202011.6reported
Q2 202021.0reported
Q1 202023.6reported
Q4 201919.1reported
Q3 201916.0reported
Q2 201913.9reported
Q1 201911.1reported
Q4 201810.0reported
Q3 20189.6reported
Q2 201811.6reported
Q1 201812.1reported
Q4 20178.1reported
Q3 20177.2reported
Q2 20176.3reported
Q1 20177.1reported
Q4 20168.9reported
Q3 20166.0reported
Q2 20165.1reported
Q1 20166.5reported

CSV with all sources · Technical ID: cash

More metrics for Meta

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$12.7B
Period
Q2 2022, ended Jun 30, 2022 · as of Jun 30, 2022 (balance as of date, not a sum)
Source
10-Q, filed Jul 28, 2022 · 0001326801-22-000082
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$12.7BJul 28, 202210-Q 0001326801-22-000082reported · confidence 1. · current